$6 Million Grant Awarded to South Texas Center of Excellence in Cancer

Translate to Spanish or other 102 languages!

The Cancer, Prevention & Research Institute of Texas (CPRIT) awarded the University of Texas Rio Grande Valley (UTRGV) a Texas Regional Excellence in Cancer (TREC) $6 million grant. Image for illustration purposes. Bgd. googlemaps
The Cancer, Prevention & Research Institute of Texas (CPRIT) awarded the University of Texas Rio Grande Valley (UTRGV) a Texas Regional Excellence in Cancer (TREC) $6 million grant. Image for illustration purposes. Bgd. googlemaps

Mega Doctor News

- Advertisement -

AUSTIN, TX — The Cancer, Prevention & Research Institute of Texas (CPRIT) awarded the University of Texas Rio Grande Valley (UTRGV) a Texas Regional Excellence in Cancer (TREC) $6 million grant. TREC is a grant program administered by CPRIT designed to strengthen cancer research at institutions located in regions of Texas that have historically received low levels of cancer research funding. Senator Juan “Chuy” Hinojosa, along with CPRIT Board Member Dr. Ambrosio Hernandez, have been advocating for more cancer funding in South Texas.

In 2021, Senator Hinojosa wrote a letter to Dee Margo, Presiding Officer of CPRIT, stating his interest in bolstering the faculty and facilities at emerging research institutions so that they to can participate in the critical research and development occurring across medical fields, including cancer research. In 2022, Senator Hinojosa wrote a letter of support for UTRGV’s application submitted to CPRIT for this grant.

Senator Hinojosa released the following statement:

- Advertisement -

“Congratulations to UTRGV for receiving this $6 million grant award from CPRIT which will further help strengthen cancer research in the Rio Grande Valley. This grant will build on the work and investments we have made locally and with direct state appropriations to increase cancer care and research in the region. I appreciate CPRIT leadership, including Dr. Ambrosio Hernandez, for their support and this award that will allow the South Texas Center of Excellence in Cancer to grow and help us address cancer related health disparities in South Texas.”

The $6 million grant to UTRGV will support the South Texas Center of Excellence in Cancer research. This Center is focused on reducing cancer health disparities in the border region. The mission of the Center is to address and provide innovative scientific discoveries, reduce cancer-related health disparities in the Rio Grande Valley, improve the quality of patient care and serve as the leader for cancer research in the RGV.PRIT Awards $6 Million Grant to the South Texas Center of Excellence in Cancer at UTRGV

See Related Stories:

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Starr County Healthcare Workforce Gets $100K Boost via New Internship Fund

Workforce Solutions (WFS) announced the launch of the $100,000 Healthcare Internship Fund, an innovative workforce development initiative designed to create structured, paid internship opportunities for 91 students pursuing high-demand healthcare careers across the region.

4th of July Fireworks Safety Guide for Parents

As families gear up for backyard barbecues, fireworks displays and other Fourth of July celebrations, safety should be part of the preparation.

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.
- Advertisement -